IVA vs REGN: Which Stock is Better?
Side-by-side comparison of Inventiva Sa and Regeneron Pharmaceuticals Inc in 2026
IVA
Inventiva Sa
$5.51
REGN
Regeneron Pharmaceuticals Inc
$755.51
Key Metrics Comparison
| Metric | IVA | REGN | Winner |
|---|---|---|---|
| Market Cap | $1.14B | $79.87B | REGN |
| P/E Ratio | N/A | 18.21 | REGN |
| EPS (TTM) | $N/A | $41.48 | REGN |
| Revenue Growth | -0.8% | 0.0% | REGN |
| Gross Margin | 100.0% | 44.6% | IVA |
Analyze IVA
Full quant analysis
Analyze REGN
Full quant analysis
Analyze Each Stock
Frequently Asked Questions
Is IVA or REGN a better investment?
Comparing IVA and REGN: Inventiva Sa has a market cap of $1.14B while Regeneron Pharmaceuticals Inc has $79.87B. Both companies have their strengths - use our detailed metrics comparison to make an informed decision.
What is the difference between IVA and REGN?
IVA (Inventiva Sa) and REGN (Regeneron Pharmaceuticals Inc) differ in valuation, growth rates, and profitability metrics. Our comparison shows which company leads in each category.
Which stock has better value: IVA or REGN?
Based on P/E ratios, compare detailed valuation metrics on our dashboard.
Which is growing faster: IVA or REGN?
REGN has higher revenue growth at 0.0% vs -0.8% for IVA.
Which company is more profitable: IVA or REGN?
Inventiva Sa (IVA) has higher gross margins at 100.0% compared to 44.6% for REGN.
Which is the larger company: IVA or REGN?
Regeneron Pharmaceuticals Inc (REGN) is larger with a market cap of $79.87B compared to $1.14B for IVA.
Should I buy IVA or REGN in 2026?
Both IVA and REGN have investment merit. IVA trades at $5.51 while REGN trades at $755.51. Consider your investment goals, risk tolerance, and portfolio diversification before deciding. Our AI analysis tools can provide personalized insights.
What are the key differences between IVA and REGN stock?
Key differences: Market Cap ($1.14B vs $79.87B), P/E Ratio (N/A vs 18.2x), Revenue Growth (-0.8% vs 0.0%), Gross Margin (100.0% vs 44.6%).